In addition to the goal of using pluripotent stem cells in regenerative medicine, The Economist writes that drug companies are also interested in using them to test drugs. Pluripotent stem cells could be used to generate "pure cultures of cells," The Economist says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Eye on iPS

Just Look Within

This Week in Cell

This Week in Cell

This Week in PLOS

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.